Abstract | PURPOSE: This article examines the outcome of radioactive iodine ablation therapy for thyroid cancer in high-risk patients and investigates background factors influencing ablation failure. MATERIALS AND METHODS: We included 91 patients in this retrospective analysis and evaluated the ablation success rate. Successful ablation was defined as the absence of visible iodine-131 (I-131) accumulation in the thyroid bed after whole-body scans and thyroglobulin levels <2 ng/ml in a TSH-stimulated state after ablation. We extracted data on patients' age, sex, I-131 dose, pathology, resection stump findings, tumor T category and thyroglobulin levels, which could affect ablation outcome. RESULTS: Successful ablation was achieved in only 14 patients (15.4%). Pre-ablation serum thyroglobulin levels were significantly higher in the ablation failure group than in the success group (P < 0.001), while no significant differences were found for other factors between the groups. Furthermore, thyroglobulin levels >10 ng/ml were significantly related to ablation failure after multivariate analysis (odds ratio 27.2; 95% confidence interval 2.469-299.7; P = 0.007). CONCLUSION: The ablation success rate was very low because of high thyroglobulin levels, even with high-dose I-131. High-risk patients, especially those with high thyroglobulin levels (>10 ng/ml), are unlikely to reach levels low enough to meet successful ablation criteria.
|
Authors | Ken Watanabe, Mayuki Uchiyama, Kunihiko Fukuda |
Journal | Japanese journal of radiology
(Jpn J Radiol)
Vol. 35
Issue 9
Pg. 505-510
(Sep 2017)
ISSN: 1867-108X [Electronic] Japan |
PMID | 28620714
(Publication Type: Journal Article)
|
Chemical References |
- Iodine Radioisotopes
- Iodine-131
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Female
- Humans
- Iodine Radioisotopes
(therapeutic use)
- Male
- Middle Aged
- Radiosurgery
(methods)
- Retrospective Studies
- Thyroid Neoplasms
(surgery)
- Treatment Outcome
- Young Adult
|